NEW YORK (360Dx) – Hennigsdorf, Germany-based Sphingotec said today that it has combined technology platforms with San Diego, California-based Nexus Dx to improve decision-making at the point of care in emergency departments and intensive care units.

Financial and other terms of the deal were not disclosed.

Holding company Polaris MediNet — jointly owned by Sphingotec and Nam Shin, CEO of Nexus Dx — merged the technology platforms.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Feb
26
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease. 

Mar
19

In this webinar, Dr. Matthew Faron, a pathologist from the Medical College of Wisconsin, will share results of a comparison study of three rapid influenza assays.

 

Mar
20
Sponsored by
Qiagen

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.